Clik here to view.
Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma
SHANGHAI Pfizer Inc. (NYSE:PFE) announced today that it has acquired Sirio Pharma Co. Ltd.’s wholly-owned subsidiary, Treerly Health Co., Ltd., and its family of Treerly products. Treerly is one of...
View ArticleClik here to view.
ラッセル・レイノルズ・アソシエイツが国際ヘルスケアおよび非営利組織部門の拡充のためワシーム・ノールを採用
ニューヨーク 大手エグゼクティブ・サーチ企業のラッセル・レイノルズ・アソシエイツは本日、ワシーム・ノールを国際製薬、バイオテクノロジー、非営利組織部門の一員として迎えたことを発表しました。ノールは、担当業界のクライアントのために上級経営管理職および取締役の評価とリクルーティングを行います。 このSmart News...
View ArticleClik here to view.
Astellas Pharma Europe: Lancet Oncology Publishes Results from the Phase 2...
CHERTSEY, England Astellas Pharma Europe Ltd., a subsidiary of Tokyo-based Astellas Pharma Inc. (TSE:4503), today announced that results from the Phase 2 TERRAIN trial of XTANDITM▼ (enzalutamide)...
View ArticleClik here to view.
GEヘルスケアとFedDev Ontarioが、細胞療法の製造上の課題解決に向け、CCRM主導の新センターに4000万カナダドルの提供を約束
英チャルフォントセントジャイルズ & トロント （ビジネスワイヤ） — GEヘルスケアとカナダ連邦オンタリオ州南部経済開発庁（FedDev Ontario）、再生医療商業化センター（CCRM)は、GEおよびFedDev...
View ArticleClik here to view.
罗盛咨询聘请Waseem Noor提振其全球医疗和非盈利业务
纽约 (美国商业资讯)–全球领先的高管猎头公司罗盛咨询(Russell Reynolds Associates)今日宣布，Waseem Noor已加入公司全球制药、生物科技和非营利性业务部门。Waseem将代表其关注行业的客户机构评估并聘请高管和董事会成员。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
胸腹部大動脈瘤の臨床試験で初の植え込みを完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、内臓分枝にまたがる大動脈瘤の治療を目的とした臨床試験で、米国初となるGORE® EXCLUDER® Thoracoabdominal Branch...
View ArticleClik here to view.
Genscript Corporation Finishes Year with Successful Hong Kong IPO
PISCATAWAY, N.J. Genscript Biotech Corporation, the number one global provider of gene synthesis services and a strong player in synthetic biology, ended 2015 with a successful IPO of 400,000,000...
View ArticleClik here to view.
Chi-Med initiates HMPL-523 Phase I clinical trial in hematological cancer in...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM: HCM) today announces that Hutchison MediPharma Limited (“HMP”), its drug R&D subsidiary, has initiated a Phase I trial in Australia in...
View ArticleClik here to view.
米国ストラテジア製薬: 富士フイルムの放射免疫療法治療薬FF-21101の進行性がんの患者さんを対象とする第1相臨床試験を開始
ボストン （ビジネスワイヤ） — ストラテジア製薬は、 富士フイルムの子会社 FUJI FILM Pharmaceuticals U.S.A., Inc. (FPHU) の主要な戦略的グローバル医薬品開発プロバイダーとして、進行性がんの患者さんを対象とした放射免疫療法治療薬FF-21101の第1相臨床試験を米国にて開始しました。この臨床試験は、ヴィベック・サビア医師（Vivek...
View ArticleClik here to view.
Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®,...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a biosimilar referencing Enbrel® (etanercept), also known as SB4 – for the treatment...
View ArticleClik here to view.
Telephus Medical LLC Announces Issuance of Japanese Patent for Anti-MRSA...
SAN DIEGO Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, today announced that the Japan...
View ArticleClik here to view.
Hudson Researcher’s Findings May Improve Cancer Drug Clinical Trial Success...
MELBOURNE, Australia A researcher from Hudson Institute of Medical Research in Melbourne, Australia, has discovered a class of biomarkers which may be used to predict which cancer patients will...
View ArticleClik here to view.
AtriCure Announces Approval for the AtriClip in Japan
WEST CHESTER, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received...
View ArticleClik here to view.
次世代産業を支える革新的新製品・技術はコレだ！新機能性材料展 159社254小間で魅せるモノづくりイノベーション！
東京 （ビジネスワイヤ） – 株式会社加工技術研究会と株式会社ICSコンベンションデザインは、機能性マテリアル・フィルムの展示会「新機能性材料展」を、1月27日（水）～29日（金）まで、東京ビッグサイトにて開催します。...
View ArticleClik here to view.
MedAdvisor Strengthens Board of Directors with Appointment of Ms Sandra Hook
MELBOURNE, Australia MedAdvisor Limited (ASX:MDR) an Australian software developer focused on improving health outcomes by placing patients at the centre of connected health platforms, today...
View ArticleClik here to view.
Phosphagenics Reports Positive Results for Weaner Pig Feed Efficiency Trial
MELBOURNE, Australia Australian drug delivery company, Phosphagenics Limited (ASX:POH; OTCQX:PPGNY), is pleased to report positive results in its initial Animal Health and Nutrition trial. This...
View ArticleClik here to view.
AtriCure宣布 AtriClip在日本获得核准
安大略省西切斯特 (美国商业资讯) — AtriCure, Inc. (Nasdaq: ATRC)是房颤(Afib)治疗和左心耳(LAA)处治领域的领先创新者，该公司今天宣布，其AtriClip™产品（包括AtriClip™标准和AtriClip Pro™器械）已获得日本厚生劳动和福祉省(MHLW)的核准。 AtriCure总裁兼首席执行官Mike...
View ArticleClik here to view.
Celltrion and Medidata Team Up to Transform Global Clinical Trials for...
NEW YORK & SEOUL, Korea Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and Korean biopharmaceutical company Celltrion...
View ArticleClik here to view.
PENTAX Europe GmbH Acquires the Remaining Shares of PENTAX Italia S.r.L. from...
HAMBURG, Germany PENTAX Europe GmbH has acquired the remaining stock of PENTAX Italia S.r.L. from Movi S.p.A. This further investment by PENTAX Europe GmbH into the Italian healthcare market...
View ArticleClik here to view.
Cytori Partner Kerastem Expands US Phase II Trial for Early Stage Hair Loss
SAN DIEGO & TOKYO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that its licensee Kerastem Technologies, LLC, has expanded STYLE, its US phase II clinical trial investigating early...
View Article